Updated: January 4, 2026
ZTlido Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
- Is ZTlido in an Official FDA Shortage in 2026?
- What's Driving ZTlido Supply Challenges?
- 1. International Manufacturing
- 2. Market Transition to Generic Competition
- 3. Specialty Product Stocking Decisions
- 4. Insurance Coverage Hurdles Reduce Predictable Demand
- ZTlido's Availability Timeline
- What Should Patients Do Right Now?
- PHN Pain Shouldn't Wait — Get Help Finding Your Medication
Is ZTlido in shortage in 2026? Get the latest update on ZTlido availability, what's causing supply issues, and what patients can do right now.
Patients who rely on ZTlido (lidocaine topical system 1.8%) for post-herpetic neuralgia pain management often wonder whether the difficulty finding it at the pharmacy means there's an official shortage. Here's an up-to-date look at ZTlido's availability status in 2026 and what it means for you.
Is ZTlido in an Official FDA Shortage in 2026?
As of 2026, ZTlido is not listed on the FDA's official Drug Shortage Database as a nationwide shortage. This is good news — it means the manufacturer (Scilex Pharmaceuticals) and its distribution network are not reporting an inability to meet national demand.
However, an absence from the shortage list does not mean ZTlido is easy to find at every pharmacy. Many patients still report difficulty locating it locally — a phenomenon known as a localized or intermittent supply disruption, which doesn't rise to the level of a formal federal shortage classification.
What's Driving ZTlido Supply Challenges?
Several factors contribute to ZTlido's inconsistent availability at the local level:
1. International Manufacturing
ZTlido is manufactured in Japan. International pharmaceutical manufacturing involves complex logistics, regulatory inspections, and shipping timelines. Any disruption — whether a GMP inspection, a port delay, or a distributor inventory issue — can create temporary local supply gaps in the U.S. before triggering any formal shortage classification.
2. Market Transition to Generic Competition
In March 2025, the FDA approved the first generic version of ZTlido (lidocaine 1.8% topical system) manufactured by Aveva Drug Delivery Systems. As the market begins transitioning, pharmacy ordering patterns may shift. Scilex (the brand manufacturer) and its distributors may adjust supply allocations, creating temporary regional availability gaps as the ecosystem adjusts.
3. Specialty Product Stocking Decisions
ZTlido is a brand-name specialty product. Unlike high-volume generics that pharmacies keep in bulk, specialty medications are often stocked only when there's demonstrated local demand. A pharmacy with few ZTlido patients may simply not order it regularly, making it unavailable on short notice.
4. Insurance Coverage Hurdles Reduce Predictable Demand
ZTlido often requires prior authorization (PA) from insurance companies, and many payers also impose step therapy — requiring patients to try the cheaper generic lidocaine 5% patch first. These barriers mean patient demand for ZTlido at the pharmacy counter is lower than it could be, reducing how aggressively pharmacies stock it.
ZTlido's Availability Timeline
2018: ZTlido received FDA approval and launched commercially
2019-2023: Growing commercial adoption; over 1 million patients treated
2024: Scilex expanded international distribution; MENA region approvals sought
March 2025: First FDA-approved generic (Aveva Drug Delivery Systems) approved
2025-2026: Market in transition; brand ZTlido available but with intermittent local stocking gaps
What Should Patients Do Right Now?
If you're having trouble filling your ZTlido prescription, here are immediate steps to take:
Call multiple pharmacies — availability is highly localized. One store may be out while another two miles away has it in stock.
Ask your pharmacy to order it — most can get ZTlido within 1-3 business days through their wholesale distributor.
Try a specialty pharmacy — specialty pharmacies often have better access to brand-name products like ZTlido.
Use medfinder — medfinder calls pharmacies on your behalf to find which ones have ZTlido in stock, so you don't have to.
Talk to your doctor about alternatives — if ZTlido remains unavailable, generic lidocaine 5% patches or oral options like gabapentin can bridge the gap.
PHN Pain Shouldn't Wait — Get Help Finding Your Medication
Post-herpetic neuralgia can be debilitating, and going without medication while you search for it makes everything worse. medfinder is a paid service that calls pharmacies near you to check ZTlido availability and texts you the results — so you can spend less time searching and more time getting relief.
Frequently Asked Questions
As of 2026, ZTlido is not listed on the FDA's official Drug Shortage Database. There is no nationwide shortage designation. However, local pharmacy availability remains inconsistent due to ZTlido's specialty product status, international manufacturing, and the market transition following the March 2025 FDA approval of the first generic lidocaine 1.8% topical system.
Most pharmacies stock ZTlido only on demand because it's a specialty brand-name medication with relatively low local prescription volume compared to widely used generics. If your pharmacy doesn't have it, they can typically order it within 1-3 business days. Try calling other nearby pharmacies, or ask your pharmacy to place an order in advance of your next refill.
The FDA approved a generic lidocaine 1.8% topical system (Aveva Drug Delivery Systems) in March 2025. Commercial launch timing depends on patent litigation outcomes and manufacturing scale-up. As of 2026, availability is limited. Check with your pharmacist for the latest information on generic availability in your area.
Patients and healthcare providers can report drug availability concerns to the FDA by emailing drugshortages@fda.hhs.gov. The FDA uses these reports to track emerging shortage patterns and work with manufacturers to prevent or shorten supply disruptions.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for ZTlido also looked for:
More about ZTlido
34,034 have already found their meds with Medfinder.
Start your search today.





